Equities

New Horizon Health Ltd

New Horizon Health Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)14.14
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-46.24%
  • Beta0.9585
Data delayed at least 15 minutes, as of Mar 27 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

New Horizon Health Ltd is a China-based investment holding company principally engaged in the research, development, clinical development, test operation and commercialization of screening products for colorectal cancer, gastric cancer and cervical cancer. The Company distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.

  • Revenue in HKD (TTM)1.47bn
  • Net income in HKD119.43m
  • Incorporated2018
  • Employees1.04k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
China Isotope & Radiation Corp7.16bn400.49m3.42bn3.11k8.550.67553.160.47781.251.2522.3915.840.53124.221.842,306,913.006.216.5712.8213.2652.4859.8911.7012.621.73--0.191928.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd569.75m-85.00m3.58bn765.00--1.06--6.28-0.2587-0.25871.7310.150.15920.9991480.65744,770.60-2.38---2.56--72.95---14.92--4.88--0.018--57.97--30.66------
Yidu Tech Inc871.30m-210.46m3.64bn902.00--0.8388--4.18-0.2001-0.20010.82854.090.1658114.901.36965,962.60-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96------
Modern Dental Group Ltd3.17bn404.10m3.88bn7.04k9.661.487.091.220.42450.42453.332.780.84689.105.49450,895.3010.747.0512.608.3453.6150.7712.689.242.5313.170.243839.9812.086.5083.3036.462.42--
Microport NeuroTech Ltd-100.00bn-100.00bn4.56bn571.00------------------------------------------------21.61--768.73------
Shanghai Conant Optical Co Ltd1.90bn353.04m4.78bn2.51k13.533.1711.502.520.82760.82764.453.530.93282.166.48757,139.4017.3412.5722.4018.6937.4035.2718.5814.642.15--0.133518.5712.7015.5631.5633.0413.49--
Shanghai INT Medical Instruments Co Ltd812.74m168.91m4.89bn1.57k28.232.6622.576.020.98470.98474.7410.470.39042.227.75518,661.307.958.639.499.7658.1959.4420.3526.161.88--0.053531.8028.5029.9618.7921.7645.75--
AK Medical Holdings Ltd1.18bn196.59m4.96bn1.05k25.171.9216.834.200.17560.17561.062.300.37870.84062.381,122,533.006.309.277.5211.2861.6665.0616.6521.782.77--0.043122.653.9712.74-11.074.6721.675.88
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd351.83m163.59m6.21bn219.0037.942.9834.5117.640.47180.47181.016.000.17170.584810.301,606,525.007.98--8.25--88.62--46.50--22.93--0.0013--31.58--864.81------
LifeTech Scientific Corp1.37bn284.19m6.44bn1.45k21.931.7733.874.700.06340.06340.30770.78580.30220.749110.46946,064.502.567.093.058.5178.5779.668.4822.692.27--0.14590.0015.4817.88-19.0916.8026.11--
New Horizon Health Ltd1.47bn119.43m6.47bn1.04k59.172.0141.624.400.2390.2393.227.040.45362.162.081,674,671.003.67--3.99--88.74--8.10--10.50--0.1305--259.54--97.40------
Shanghai MicroPort MedBot Group Co Ltd112.91m-1.09bn6.62bn650.00--11.64--58.59-1.14-1.140.11780.5850.06230.374642.10173,715.10-60.96---86.19--14.05---978.59--0.8238-11.040.5427--384.16--11.20------
Kangji Medical Holdings Ltd999.71m544.13m6.79bn1.00k12.051.7312.966.790.4640.4640.85253.240.22451.764.76996,720.3010.9714.4012.4516.1880.0481.7548.8457.2417.16--0.01149.5817.7621.235.2828.0041.50--
Angelalign Technology Inc1.59bn57.73m8.95bn2.88k154.642.4861.945.620.34210.34219.4421.330.31945.3316.70552,692.101.055.761.297.5962.3864.333.3013.984.12--0.0188--16.2424.75-74.99-2.2020.54--
MicroPort Scientific Corp7.42bn-3.73bn9.65bn8.23k--1.63--1.30-2.04-2.044.073.220.23991.095.32901,790.90-16.38-11.85-27.68-18.0455.9762.96-68.28-44.431.26-4.210.5477--13.077.27-9.42--19.44--
Data as of Mar 27 2024. Currency figures normalised to New Horizon Health Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Invesco Advisers, Inc.as of 25 Jul 202430.15m0.00%
Janus Henderson Investors US LLCas of 03 Jul 202416.24m0.00%
The Vanguard Group, Inc.as of 04 Jul 202413.19m0.00%
China Asset Management Co., Ltd.as of 31 Dec 20235.12m0.00%
RBC Global Asset Management (Asia) Ltd.as of 31 May 20244.17m0.00%
Norges Bank Investment Managementas of 31 Dec 20234.16m0.00%
BlackRock Fund Advisorsas of 04 Jul 20243.46m0.00%
Baillie Gifford & Co.as of 30 Jun 20243.42m0.00%
Bosera Asset Management Co., Ltd.as of 31 Dec 20222.25m0.00%
Carmignac Gestion SAas of 28 Mar 20242.08m0.00%
More ▼
Data from 31 Dec 2023 - 24 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.